Gene therapy with the p53 tumor suppressor gene in an adenovirus vector data

University researchers reported results of a Phase I trial of Introgen's p53 gene therapy in lung

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE